The estimated Net Worth of Giandomenico Trombetta is at least $10.3 millió dollars as of 6 December 2021. Giandomenico Trombetta owns over 99,378 units of Milestone Scientific stock worth over $9,902,004 and over the last 9 years Giandomenico sold MLSS stock worth over $403,612.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Giandomenico Trombetta MLSS stock SEC Form 4 insiders trading
Giandomenico has made over 9 trades of the Milestone Scientific stock since 2016, according to the Form 4 filled with the SEC. Most recently Giandomenico exercised 99,378 units of MLSS stock worth $159,999 on 6 December 2021.
The largest trade Giandomenico's ever made was buying 1,000,000 units of Milestone Scientific stock on 29 June 2016 worth over $2,000,000. On average, Giandomenico trades about 90,714 units every 86 days since 2016. As of 6 December 2021 Giandomenico still owns at least 10,261,144 units of Milestone Scientific stock.
You can see the complete history of Giandomenico Trombetta stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Giandomenico Trombetta's mailing address?
Giandomenico's mailing address filed with the SEC is C/O MILESTONE SCIENTIFIC INC., 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND, NJ, 07068.
Insiders trading at Milestone Scientific
Over the last 17 years, insiders at Milestone Scientific have traded over $3,338,839 worth of Milestone Scientific stock and bought 3,404,030 units worth $4,625,304 . The most active insiders traders include Giandomenico Trombetta, Leonard Osser és Joseph D'agostino. On average, Milestone Scientific executives and independent directors trade stock every 68 days with the average trade being worth of $73,138. The most recent stock trade was executed by Leonard Osser on 21 August 2024, trading 141,913 units of MLSS stock currently worth $134,817.
What does Milestone Scientific do?
milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.
What does Milestone Scientific's logo look like?
Complete history of Giandomenico Trombetta stock trades at Milestone Scientific
Milestone Scientific executives and stock owners
Milestone Scientific executives and other stock owners filed with the SEC include:
-
Leonard A. Osser,
Founder, Vice Chairman & MD of China Operations -
Leonard Osser,
Director -
Joseph D'Agostino,
Chief Financial Officer, Chief Operating Officer -
Jan Adriaan Haverhals,
Pres & CEO -
Gian Trombetta,
Director -
Leslie Bernhard,
Independent Non-Executive Chairman of the Board -
Leonard Schiller,
Independent Director -
Michael McGeehan,
Independent Director -
Neal Goldman,
Independent Director -
Mark Hochman,
Director of Clinical Affairs -
Eugene Casagrande,
Director of International Professional Relations -
Jan Haverhals,
President, Chief Executive Officer, Chief Executive Office of Milestone Dental Division -
Keisha Harcum,
Controller -
James McAvinn,
Sr. VP of Sales & Marketing -
S.R.L.Innovest Sp A Bp4,
See RemarksSee Remarks -
Steven F Robins,
President -
Cardenas Pablo Felipe Serna,
Director -
Edward J. Zelnick,
Director -
Daniel S Goldberger,
President and CEO -
Robert A. Presutti,
VP of Sales & Marketing -
Jeffrey Fuller,
Director -
Brent W Johnston,
President -
Benedetta I Casamento,
Director -
Peter J Milligan,
President